Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

378 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
PET imaging with a [68Ga]gallium-labelled PSMA ligand for the diagnosis of prostate cancer: biodistribution in humans and first evaluation of tumour lesions.
Afshar-Oromieh A, Malcher A, Eder M, Eisenhut M, Linhart HG, Hadaschik BA, Holland-Letz T, Giesel FL, Kratochwil C, Haufe S, Haberkorn U, Zechmann CM. Afshar-Oromieh A, et al. Among authors: hadaschik ba. Eur J Nucl Med Mol Imaging. 2013 Apr;40(4):486-95. doi: 10.1007/s00259-012-2298-2. Epub 2012 Nov 24. Eur J Nucl Med Mol Imaging. 2013. PMID: 23179945
Reply to Reske et al.: PET imaging with a [68Ga]gallium-labelled PSMA ligand for the diagnosis of prostate cancer: biodistribution in humans and first evaluation of tumour lesions.
Afshar-Oromieh A, Malcher A, Eder M, Eisenhut M, Linhart HG, Hadaschik BA, Holland-Letz T, Giesel FL, Kratochwil C, Haufe S, Haberkorn U, Zechmann CM. Afshar-Oromieh A, et al. Among authors: hadaschik ba. Eur J Nucl Med Mol Imaging. 2013 Jun;40(6):971-2. doi: 10.1007/s00259-013-2386-y. Epub 2013 Apr 5. Eur J Nucl Med Mol Imaging. 2013. PMID: 23558688 No abstract available.
PET/MRI with a 68Ga-PSMA ligand for the detection of prostate cancer.
Afshar-Oromieh A, Haberkorn U, Hadaschik B, Habl G, Eder M, Eisenhut M, Schlemmer HP, Roethke MC. Afshar-Oromieh A, et al. Eur J Nucl Med Mol Imaging. 2013 Oct;40(10):1629-30. doi: 10.1007/s00259-013-2489-5. Epub 2013 Jul 2. Eur J Nucl Med Mol Imaging. 2013. PMID: 23817686 No abstract available.
Hybrid positron emission tomography-magnetic resonance imaging with gallium 68 prostate-specific membrane antigen tracer: a next step for imaging of recurrent prostate cancer-preliminary results.
Roethke MC, Kuru TH, Afshar-Oromieh A, Schlemmer HP, Hadaschik BA, Fenchel M. Roethke MC, et al. Among authors: hadaschik ba. Eur Urol. 2013 Nov;64(5):862-4. doi: 10.1016/j.eururo.2013.08.003. Epub 2013 Aug 9. Eur Urol. 2013. PMID: 23954084 No abstract available.
Comparison of PET imaging with a (68)Ga-labelled PSMA ligand and (18)F-choline-based PET/CT for the diagnosis of recurrent prostate cancer.
Afshar-Oromieh A, Zechmann CM, Malcher A, Eder M, Eisenhut M, Linhart HG, Holland-Letz T, Hadaschik BA, Giesel FL, Debus J, Haberkorn U. Afshar-Oromieh A, et al. Among authors: hadaschik ba. Eur J Nucl Med Mol Imaging. 2014 Jan;41(1):11-20. doi: 10.1007/s00259-013-2525-5. Epub 2013 Sep 27. Eur J Nucl Med Mol Imaging. 2014. PMID: 24072344 Free PMC article.
Comparison of PET/CT and PET/MRI hybrid systems using a 68Ga-labelled PSMA ligand for the diagnosis of recurrent prostate cancer: initial experience.
Afshar-Oromieh A, Haberkorn U, Schlemmer HP, Fenchel M, Eder M, Eisenhut M, Hadaschik BA, Kopp-Schneider A, Röthke M. Afshar-Oromieh A, et al. Among authors: hadaschik ba. Eur J Nucl Med Mol Imaging. 2014 May;41(5):887-97. doi: 10.1007/s00259-013-2660-z. Epub 2013 Dec 19. Eur J Nucl Med Mol Imaging. 2014. PMID: 24352789
Radiation dosimetry and first therapy results with a (124)I/ (131)I-labeled small molecule (MIP-1095) targeting PSMA for prostate cancer therapy.
Zechmann CM, Afshar-Oromieh A, Armor T, Stubbs JB, Mier W, Hadaschik B, Joyal J, Kopka K, Debus J, Babich JW, Haberkorn U. Zechmann CM, et al. Eur J Nucl Med Mol Imaging. 2014 Jul;41(7):1280-92. doi: 10.1007/s00259-014-2713-y. Epub 2014 Feb 28. Eur J Nucl Med Mol Imaging. 2014. PMID: 24577951 Free PMC article.
The diagnostic value of PET/CT imaging with the (68)Ga-labelled PSMA ligand HBED-CC in the diagnosis of recurrent prostate cancer.
Afshar-Oromieh A, Avtzi E, Giesel FL, Holland-Letz T, Linhart HG, Eder M, Eisenhut M, Boxler S, Hadaschik BA, Kratochwil C, Weichert W, Kopka K, Debus J, Haberkorn U. Afshar-Oromieh A, et al. Among authors: hadaschik ba. Eur J Nucl Med Mol Imaging. 2015 Feb;42(2):197-209. doi: 10.1007/s00259-014-2949-6. Epub 2014 Nov 20. Eur J Nucl Med Mol Imaging. 2015. PMID: 25411132 Free PMC article.
Comparison of hybrid (68)Ga-PSMA PET/MRI and (68)Ga-PSMA PET/CT in the evaluation of lymph node and bone metastases of prostate cancer.
Freitag MT, Radtke JP, Hadaschik BA, Kopp-Schneider A, Eder M, Kopka K, Haberkorn U, Roethke M, Schlemmer HP, Afshar-Oromieh A. Freitag MT, et al. Among authors: hadaschik ba. Eur J Nucl Med Mol Imaging. 2016 Jan;43(1):70-83. doi: 10.1007/s00259-015-3206-3. Epub 2015 Oct 28. Eur J Nucl Med Mol Imaging. 2016. PMID: 26508290
378 results